Nitrous oxide production in sputum from cystic fibrosis patients with chronic Pseudomonas aeruginosa lung infection

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Kolpen, Mette ^a,b   Kühl, Michael ^c,d,e   Bjarnsholt, Thomas ^a,b   Moser, Claus ^a   Hansen, Christine Rønne ^a   Liengaard, Lars ^c   Kharazmi, Arsalan ^a   Pressler, Tanja ^a   Høiby, Niels ^a,b   Jensen, Peter Østrup ^a  

^a Rigshospitalet   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d UNIVERSITY OF TECHNOLOGY SYDNEY   (Australia)

^e NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

NITRATE; NITROGEN DIOXIDE; NITROUS OXIDE; OXYGEN;

ADULT; ANAEROBIC GROWTH; ARTICLE; BACTERIAL GROWTH; BACTERIAL METABOLISM; BRONCHUS MUCUS; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; DENITRIFICATION; FEMALE; HUMAN; LUNG INFECTION; MALE; NONHUMAN; PSEUDOMONAS INFECTION; SIGNAL TRANSDUCTION; SPUTUM ANALYSIS; SPUTUM LEVEL;

ADULT; BIOSENSING TECHNIQUES; CHRONIC DISEASE; CYSTIC FIBROSIS; DEMOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; NITRATES; NITRITES; NITROUS OXIDE; OXYGEN; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; SPUTUM; YOUNG ADULT;

EID: 84897964314     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0084353     Document Type: Article

References (63)

1. Riordan JR, Rommens JM, Kerem B, Alon N, Rozmahel R, et al. (1989) Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 245: 1066-1073. (Pubitemid 19231814)
2. Knowles MR, Boucher RC (2002) Mucus clearance as a primary innate defense mechanism for mammalian airways. J Clin Invest 109: 571-577. (Pubitemid 34204834)
3. Boucher RC (2007) Evidence for airway surface dehydration as the initiating event in CF airway disease. J Intern Med 261: 5-16.
4. Koch C, Høiby N (1993) Pathogenesis of cystic fibrosis. Lancet 341: 1065-1069. (Pubitemid 23114408)
5. Koch C, Høiby N (2000) Diagnosis and treatment of cystic fibrosis. Respiration 67: 239-247. (Pubitemid 30330412)
6. Worlitzsch D, Tarran R, Ulrich M, Schwab U, Cekici A, et al. (2002) Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients. J Clin Invest 109: 317-325. (Pubitemid 34141805)
7. Bjarnsholt T, Jensen PØ, Fiandaca MJ, Pedersen J, Hansen CR, et al. (2009) Pseudomonas aeruginosa biofilms in the respiratory tract of cystic fibrosis patients. Pediatr Pulmonol 44: 547-558.
8. Yang L, Haagensen JA, Jelsbak L, Johansen HK, Sternberg C, et al. (2008) In situ growth rates and biofilm development of Pseudomonas aeruginosa populations in chronic lung infections. J Bacteriol 190: 2767-2776. (Pubitemid 351508176)
9. Pedersen SS, Moller H, Espersen F, Sorensen CH, Jensen T, et al. (1992). Mucosal immunity to Pseudomonas aeruginosa alginate in cystic fibrosis. APMIS 100: 326-334.
10. Bjarnsholt T, Jensen PØ, Burmolle M, Hentzer M, Haagensen JA, et al. (2005) Pseudomonas aeruginosa tolerance to tobramycin, hydrogen peroxide and polymorphonuclear leukocytes is quorum-sensing dependent. Microbiology 151: 373-383.
11. Jensen PØ, Bjarnsholt T, Phipps R, Rasmussen TB, Calum H, et al. (2007) Rapid necrotic killing of polymorphonuclear leukocytes is caused by quorum-sensing- controlled production of rhamnolipid by Pseudomonas aeruginosa. Microbiology 153: 1329-1338. (Pubitemid 46779989)
12. van GM, Christensen LD, Alhede M, Phipps R, Jensen PØ, et al. (2009) Inactivation of the rhlA gene in Pseudomonas aeruginosa prevents rhamnolipid production, disabling the protection against polymorphonuclear leukocytes. APMIS 117: 537-546.
13. Alhede M, Bjarnsholt T, Jensen PØ, Phipps RK, Moser C, et al. (2009) Pseudomonas aeruginosa recognizes and responds aggressively to the presence of polymorphonuclear leukocytes. Microbiology 155: 3500-3508.
14. Kolpen M, Hansen CR, Bjarnsholt T, Moser C, Christensen LD, et al. (2010) Polymorphonuclear leucocytes consume oxygen in sputum from chronic Pseudomonas aeruginosa pneumonia in cystic fibrosis. Thorax 65: 57-62.
15. Hassett DJ, Cuppoletti J, Trapnell B, Lymar SV, Rowe JJ, et al. (2002) Anaerobic metabolism and quorum sensing by Pseudomonas aeruginosa biofilms in chronically infected cystic fibrosis airways: rethinking antibiotic treatment strategies and drug targets. Adv Drug Deliv Rev 54: 1425-1443. (Pubitemid 35375769)
16. Yoon SS, Hennigan RF, Hilliard GM, Ochsner UA, Parvatiyar K, et al. (2002) Pseudomonas aeruginosa anaerobic respiration in biofilms: relationships to cystic fibrosis pathogenesis. Dev Cell 3: 593-603. S1534580702002952 [pii].
17. Zumft WG (1997) Cell biology and molecular basis of denitrification. Microbiol Mol Biol Rev 61: 533-616.
18. Andersen K, Kjær T, Revsbech NP (2001) An oxygen insentitive microsensor for nitrous oxide. Sensors & Actuators B: Chemical 81: 42-48. (Pubitemid 33103624)
19. Richardson DJ (2000) Bacterial respiration: a flexible process for a changing environment. Microbiology 146 (Pt 3): 551-571.
20. Philippot L (2002) Denitrifying genes in bacterial and Archaeal genomes. Biochim Biophys Acta 1577: 355-376.
21. Philippot L (2005) Denitrification in pathogenic bacteria: for better or worst? Trends Microbiol 13: 191-192.
22. Zumft WG (2005) Nitric oxide reductases of prokaryotes with emphasis on the respiratory, heme-copper oxidase type. J Inorg Biochem 99: 194-215.
23. Schreiber F, Stief P, Gieseke A, Heisterkamp IM, Verstraete W, et al. (2010) Denitrification in human dental plaque. BMC Biol 8: 24.
24. Mitsui T, Kondo T (2004) Increased breath nitrous oxide after ingesting nitrate in patients with atrophic gastritis and partial gastrectomy. Clin Chim Acta 345: 129-133. (Pubitemid 38749181)
25. 2O generation by bacterial nitric oxide reductase. Science 330: 1666-1670.
26. Arai H, Igarashi Y, Kodama T (1995) The structural genes for nitric oxide reductase from Pseudomonas aeruginosa. Biochim Biophys Acta 1261: 279-284.
27. Gaston B, Ratjen F, Vaughan JW, Malhotra NR, Canady RG, et al. (2002) Nitrogen redox balance in the cystic fibrosis airway: effects of antipseudomonal therapy. Am J Respir Crit Care Med 165: 387-390. (Pubitemid 34118514)
28. SooHoo CK, Hollocher TC (1991) Purification and characterization of nitrous oxide reductase from Pseudomonas aeruginosa strain P2. J Biol Chem 266: 2203-2209.
29. Son MS, Matthews WJ Jr, Kang Y, Nguyen DT, Hoang TT (2007) In vivo evidence of Pseudomonas aeruginosa nutrient acquisition and pathogenesis in the lungs of cystic fibrosis patients. Infect Immun 75: 5313-5324. (Pubitemid 350033619)
30. Hassett DJ (1996) Anaerobic production of alginate by Pseudomonas aeruginosa: alginate restricts diffusion of oxygen. J Bacteriol 178: 7322-7325.
31. Jones KL, Hegab AH, Hillman BC, Simpson KL, Jinkins PA, et al. (2000) Elevation of nitrotyrosine and nitrate concentrations in cystic fibrosis sputum. Pediatr Pulmonol 30: 79-85.
32. Palmer KL, Brown SA, Whiteley M (2007) Membrane-bound nitrate reductase is required for anaerobic growth in cystic fibrosis sputum. J Bacteriol 189: 4449-4455. (Pubitemid 46919632)
33. Grasemann H, Michler E, Wallot M, Ratjen F (1997) Decreased concentration of exhaled nitric oxide (NO) in patients with cystic fibrosis. Pediatr Pulmonol 24: 173-177. (Pubitemid 27431226)
34. Linnane SJ, Keatings VM, Costello CM, Moynihan JB, O'Connor CM, et al. (1998) Total sputum nitrate plus nitrite is raised during acute pulmonary infection in cystic fibrosis. Am J Respir Crit Care Med 158: 207-212. (Pubitemid 28337182)
35. Ratjen F, Gartig S, Wiesemann HG, Grasemann H (1999) Effect of inhaled nitric oxide on pulmonary function in cystic fibrosis. Respir Med 93: 579-583. (Pubitemid 29476268)
36. Grasemann H, Grasemann C, Kurtz F, Tietze-Schillings G, Vester U, et al. (2005) Oral L-arginine supplementation in cystic fibrosis patients: a placebocontrolled study. Eur Respir J 25: 62-68. (Pubitemid 40207732)
37. Grasemann H, Tullis E, Ratjen F (2013) A randomized controlled trial of inhaled l-Arginine in patients with cystic fibrosis. J Cyst Fibros. Available: http://dx.doi.org/10.1016/j.jcf.2012.12.008.
38. Einsle O, Messerschmidt A, Stach P, Bourenkov GP, Bartunik HD, et al. (1999) Structure of cytochrome c nitrite reductase. Nature 400: 476-480. (Pubitemid 29361804)
39. Einsle O, Messerschmidt A, Huber R, Kroneck PMH, Neese F (2002) Mechanism of the six-electron reduction of nitrite to ammonia by cytochrome c nitrite reductase. J Am Chem Soc 124; 11737-11745.
40. Planelles G (2007) Ammonium homeostasis and human Rhesus glycoproteins. Nephron Physiol 105; 11-17.
41. Williams DR, Rowe JJ, Romero P, Eagon RG (1978) Denitrifying Pseudomonas aeruginosa : some parameters of growth and active transport. Appl Environ Microbiol 36: 257-263. (Pubitemid 8403246)
42. Hoffman LR, Richardson AR, Houston LS, Kulasekara HD, Martens-Habbena W, et al. (2010) Nutrient availability as a mechanism for selection of antibiotic tolerant Pseudomonas aeruginosa within the CF airway. PLoS Pathog 6: e1000712.
43. Thomas KL, Lloyd D, Boddy L (1994) Effects of oxygen, pH and nitrate concentration on denitrification by Pseudomonas species. FEMS Microbiol Lett 118: 181-186. (Pubitemid 24165159)
44. Seneterre E, Paganin F, Bruel JM, Michel FB, Bousquet J (1994) Measurement of the internal size of bronchi using high resolution computed tomography (HRCT). Eur Respir J 7: 596-600. (Pubitemid 24099021)
45. Hampton T, Armstrong S, Russell WJ (2000) Estimating the diameter of the left main bronchus. Anaesth Intensive Care 28: 540-542.
46. Arai H (2011) Regulation and Function of Versatile Aerobic and Anaerobic Respiratory Metabolism in Pseudomonas aeruginosa. Front Microbiol 2: 103.
47. Beckmann C, Brittnacher M, Ernst R, Mayer-Hamblett N, Miller SI, et al. (2005) Use of phage display to identify potential Pseudomonas aeruginosa gene products relevant to early cystic fibrosis airway infections. Infect Immun 73: 444-452. (Pubitemid 40041138)
48. Van Alst NE, Wellington M, Clark VL, Haidaris CG, Iglewski BH (2009) Nitrite reductase NirS is required for type III secretion system expression and virulence in the human monocyte cell line THP-1 by Pseudomonas aeruginosa. Infect Immun 77: 4446-4454.
49. Williams DR, Rowe JJ, Romero P, Eagon RG (1978) Denitrifying Pseudomonas aeruginosa : some parameters of growth and active transport. Appl Environ Microbiol 36: 257-263. (Pubitemid 8403246)
50. Borriello G, Werner E, Roe F, Kim AM, Ehrlich GD, et al (2004) Oxygen limitation contributes to antibiotic tolerance of Pseudomonas aeruginosa in biofilms. Antimicrob Agents Chemother 48: 2659-2664. (Pubitemid 38823439)
51. Lee B, Schjerling CK, Kirkby N, Hoffmann N, Borup R, et al (2011) Mucoid Pseudomonas aeruginosa isolates maintain the biofilm formation capacity and the gene expression profiles during the chronic lung infection of CF patients. APMIS 119: 263-274.
52. Kakishima K, Shiratsuchi A, Taoka A, Nakanishi Y, Fukumori Y (2007) Participation of nitric oxide reductase in survival of Pseudomonas aeruginosa in LPS-activated macrophages. Biochem Biophys Res Commun 355: 587-591. (Pubitemid 46282667)
53. Arai H, Iiyama K (2013) Role of nitric oxide-detoxifying enzymes in the virulence of Pseudomonas aeruginosa against the silkworm, Bombyx mori. Biosci Biotechnol Biochem 77: 198-200. DN/JST.JSTAGE/bbb/120656 [pii].
54. Shimizu T, Tsutsuki H, Matsumoto A, Nakaya H, Noda M (2012) The nitric oxide reductase of enterohaemorrhagic Escherichia coli plays an important role for the survival within macrophages. Mol Microbiol 85: 492-512.
55. Stevanin TM, Moir JW, Read RC (2005) Nitric oxide detoxification systems enhance survival of Neisseria meningitidis in human macrophages and in nasopharyngeal mucosa. Infect Immun 73: 3322-3329. (Pubitemid 40745873)
56. Loisel-Meyer S, Jimenez de Bagues MP, Basseres E, Dornand J, Kohler S, et al. (2006) Requirement of norD for Brucella suis virulence in a murine model of in vitro and in vivo infection. Infect Immun 74: 1973-1976. (Pubitemid 43346839)
57. Høiby N (2000) Microbiology of cystic fibrosis. In: Hodson ME GD, editors. Cystic fibrosis. London, UK: Arnold. pp. 83-107.
58. 2 concentration. Limnol Oceanogr 43: 1932-1937.
59. Weiss RF, Price BA (1980) Nitrous oxide solubility in water and seawater. Marine Chemistry 8: 347-359. (Pubitemid 10150957)
60. de Beer D, Stoodley P (2006) Microbial biofilms. In: Dworkin M, Falkow S, Rosenberg E, Schleifer KH, Stackebrandt E, editors. The Prokaryotes. New York: Springer Science. pp. 904-937.
61. Broecker WS, Peng TH (1974) Gas-exchange rates between air and sea. Tellus 26: 21-35.
62. 2 depletion in soil after liquid manure injection. European journal of soil science 62: 541-550.
63. 2O from tropical wetland soil (Pantanal, South America). Frontiers in Microbiology 3: 433. doi: 10.3389/fmicb.2012.00433.